The effect of recombinant IGF-I on anterior pituitary function in healthy volunteers

P J Trainer; J Holly; S Medbak; L H Rees; G M Besser

The effect of recombinant IGF-I on anterior pituitary function in healthy volunteers

P J Trainer
, J Holly
, S Medbak
, L H Rees
, G M Besser

Bristol Medical School (THS)

Research output: Contribution to journal › Article (Academic Journal) › peer-review

18 Citations (Scopus)

Abstract

Insulin-like growth factor-I is the mediator of many of the actions of GH and is a potent metabolic regulator. Recombinant IGF-I (rhIGF-I) is of potential value in the treatment of syndromes associated with either GH or insulin resistance. This study was designed to assess the effects of subcutaneous (s.c.) rhIGF-I on anterior pituitary function.

Original language	English
Pages (from-to)	801-7
Number of pages	7
Journal	Clinical Endocrinology
Volume	41
Issue number	6
Publication status	Published - 1994

Handle.net

Persistent link

Cite this

@article{d09851d432ee4a7d8c3bbc0138513f83,

title = "The effect of recombinant IGF-I on anterior pituitary function in healthy volunteers",

abstract = "Insulin-like growth factor-I is the mediator of many of the actions of GH and is a potent metabolic regulator. Recombinant IGF-I (rhIGF-I) is of potential value in the treatment of syndromes associated with either GH or insulin resistance. This study was designed to assess the effects of subcutaneous (s.c.) rhIGF-I on anterior pituitary function.",

author = "Trainer, \{P J\} and J Holly and S Medbak and Rees, \{L H\} and Besser, \{G M\}",

year = "1994",

language = "English",

volume = "41",

pages = "801--7",

journal = "Clinical Endocrinology",

issn = "0300-0664",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - The effect of recombinant IGF-I on anterior pituitary function in healthy volunteers

AU - Trainer, P J

AU - Holly, J

AU - Medbak, S

AU - Rees, L H

AU - Besser, G M

PY - 1994

Y1 - 1994

N2 - Insulin-like growth factor-I is the mediator of many of the actions of GH and is a potent metabolic regulator. Recombinant IGF-I (rhIGF-I) is of potential value in the treatment of syndromes associated with either GH or insulin resistance. This study was designed to assess the effects of subcutaneous (s.c.) rhIGF-I on anterior pituitary function.

AB - Insulin-like growth factor-I is the mediator of many of the actions of GH and is a potent metabolic regulator. Recombinant IGF-I (rhIGF-I) is of potential value in the treatment of syndromes associated with either GH or insulin resistance. This study was designed to assess the effects of subcutaneous (s.c.) rhIGF-I on anterior pituitary function.

M3 - Article (Academic Journal)

C2 - 7889617

SN - 0300-0664

VL - 41

SP - 801

EP - 807

JO - Clinical Endocrinology

JF - Clinical Endocrinology

IS - 6

ER -

The effect of recombinant IGF-I on anterior pituitary function in healthy volunteers

Abstract

Handle.net

Fingerprint

Cite this